Navigation Links
Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
Date:11/14/2012

PRINCETON, N.J., Nov. 14, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today its financial results for the third quarter ended September 30, 2012.

Soligenix's revenues for the quarter ended September 30, 2012 were $931,627 as compared to $5,795,862 for the third quarter of 2011. Revenues for the third quarter of 2011 included grant revenues of $795,862 and license revenue of $5,000,000 from Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) for rights to orBec® (oral beclomethasone 17,21-dipropionate or BDP) in the European territory.  Grant revenue increased by $135,765 and was primarily related to increased reimbursable costs from the Company's ThermoVax™, Thermostability Technology Grant focused on a novel method of rendering aluminum salt adjuvanted vaccines stable at elevated temperatures. 

Soligenix's net (loss) for the quarter ended September 30, 2012 was $758,966 or $(0.07) per share, as compared to a net income of $2,204,874 or $0.20 per share for the quarter ended September 30, 2011, representing an increased loss of $2,963,840. The increased loss is primarily related to the execution of the license with Sigma-Tau for rights to the European territory in the third quarter of 2011.    

Research and development expenses for the quarter ended September 30, 2012 were $371,338 as compared to $2,342,253 for the quarter ended September 30, 2011. The significant decrease of $1,970,915 is attributable to payment of approximately $1,000,000 in the form of cash and company stock in connection with the Sigma-Tau European territory license agreement and decreased spending associated with the discontinuation of the confirmatory Phase 3 clinical trial of orBec® for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).  General and administrative expenses for the qu
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
2. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
3. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
4. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
5. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
6. Groupe Athena, Inc. Reports Record First Quarter Revenues, Adoption Of IFRS Accounting Standard In Anticipation Of Applying For Listing On The NASDAQ Bulletin Board
7. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
8. Rochester Medical Reports Record Fourth Quarter and Fiscal Year Results
9. Heska Reports Third Quarter 2012 Earnings
10. Vermillion Reports Third Quarter 2012 Results
11. Omeros Corporation Reports Third Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... BRUNSWICK, N.J. , May 7, 2015 ... a first-of-its-kind partnership that enlists a third party to ... Johnson & Johnson (Janssen) for compassionate use ... as a pilot program focused on a single Janssen ... that will be applicable more broadly across Johnson & ...
(Date:5/6/2015)... May 6, 2015  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be presenting at the Bank of America Merrill ... in Las Vegas, Nevada on Wednesday, ... A live webcast of the presentation can be accessed via ... will be archived for replay following the conference. ...
(Date:5/6/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw LLP, ... possible breaches of fiduciary duty and other violations of ... agreeing to sell the Company to Alexion.  On May ... Alexion to acquire GEVA in a transaction valued at ...
Breaking Medicine Technology:Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 2Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 3Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 4Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 5WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2
... Dec. 9, 2011 /PRNewswire-iReach/ -- Novel Health ... the publication of  2010-2011 market trends study called ,What,s ... The published article is an analysis of sales, pricing, ... specialty biologic products. This study highlights several emerging trends ...
... FRAMINGHAM, Mass. and SYDNEY, Dec. 9, 2011 HeartWare ... HIN), a leading innovator of less invasive, miniaturized circulatory ... heart failure, today announced that CEO Doug Godshall is ... Conference at 10:50 a.m. EST on Wednesday, December 14, ...
Cached Medicine Technology:Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 2Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 3Biotech Market Trends Study Shows New Competitive Dynamics and Increasing Reimbursement Hurdles 4HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference 2
(Date:5/7/2015)... May 07, 2015 Centurion Service ... is proud to announce the upcoming live auction to ... surgery centers and other medical facilities from around the ... including radiology, surgery, endoscopy, lab, anesthesia, infusion, exam and ... Tuesday, May 12 starting at 9:00am PDT. The equipment ...
(Date:5/7/2015)... May 07, 2015 More than most public ... With constant media attention personal issues become public affairs and ... SCI TV , industry expert Katharine Nohr ... profile athletes Justin Gatlin and Michael Phelps. , With a ... her to start her own company, Nohr Sports Risk Management. ...
(Date:5/7/2015)... Wisconsin (PRWEB) May 07, 2015 When people ... give more consideration to their roofs than their basements. However, ... for flooding in crawlspaces and basements. While flooding is an ... to keep crawlspaces and unfinished areas dry to avoid a ... of a Damp Basement, Even small amounts of water can ...
(Date:5/7/2015)... (PRWEB) May 07, 2015 Aureus Medical ... travel nursing jobs and a variety of ... has released an infographic spotlighting top theme parks ... is aimed at thrill-seeking mobile healthcare professionals who are ... Travel healthcare careers offer an opportunity for the travel ...
(Date:5/7/2015)... 07, 2015 Dynamic Path, a leader ... its new free Alcohol Safety Exam Prep module ... restaurant managers, professional bartenders, and any front-of-house staff who ... Certification. The material encompasses topics taught in the National ... students can take the ServSafe Alcohol Proctored Exam or ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:Katharine Nohr Discusses Risk Management in Sports on SCI TV 2Health News:Katharine Nohr Discusses Risk Management in Sports on SCI TV 3Health News:Spring Storms Bring Musty Smell Inside 2Health News:Spring Storms Bring Musty Smell Inside 3Health News:Get to Know the Top Theme Parks: Aureus Medical Releases Infographic for the Travel Nurse and Other Travel Healthcare Professionals 2Health News:Dynamic Path Adds Alcohol Safety Exam Prep Module to Test Preparation Offerings 2
... between ages 15 and 45. When a tumor is found, ... way it's removed, which often leaves men infertile, //can change ... all men who have testicular tumors in one testicle will ... they will have no hormonproduction and no possibility for fertility. ...
... fight another. Researchers say the little-known virus GBV-C, also ... a key to helping researchers devise new strategies against ... Multicenter Acquired Immunodeficiency Syndrome Cohort Study, in which investigators ... United States for more than 15 years. The study ...
... fluids may do more harm than good for patients ... previous studies to determine if recommending patients with respiratory ... shown during a respiratory infection, such as a cold ... specific hormone that conserves water. Thus, researchers say giving ...
... errors that occur in pediatric intensive care units are more ... more than 11,800 children who were admitted into pediatric intensive ... defined an error as any preventable event that may cause ... were reported during the course of the study. Nearly 70 ...
... can no longer be considered a benign condition or ... 60 percent of overweight children have at least one ... type 2 diabetes is increasing rapidly in developing countries ... 2 diabetes in developing countries has been attributed to ...
... or other painkillers that is characterized by the onset ... after taking the medications. British researchers analyzed more than ... percent of adults and about 5 percent of children ... these patients were also sensitive to over-the-counter non-steroidal anti-inflammatory ...
Cached Medicine News:Health News:Childhood Weight Gain Found To Increase The Risk of Diabetes 2
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
Medicine Products: